Combe B, Eliaou J F, Daurès J P, Meyer O, Clot J, Sany J
Department of Rheumatology, Bichat Hospital, Paris, France.
Br J Rheumatol. 1995 Jun;34(6):529-34. doi: 10.1093/rheumatology/34.6.529.
Clinical and biological profiles at the onset of the disease, obtained retrospectively, and human leucocyte antigen typing were studied in 47 rheumatoid arthritis (RA) patients with severe articular damage (group 1) and in 47 patients with limited radiological abnormalities (group 2). The two groups were matched according to disease duration (mean: 8.1 yr). Systemic manifestations were more frequent in group 1. Erythrocyte sedimentation rate (ESR), platelet counts, C-reactive protein (CRP), rheumatoid factor and IgG titres were higher and haemoglobin level lower in group 1. HLA class II genotyping demonstrated that 95.7% of patients in group 1 were Dw4, Dw14 or DR1 as compared to 55.3% in group 2 and 37.1% in normal controls. Two RA-linked DRB1 genes were detected in 34.1% of patients in group 1, vs 8.5% in group 2 and 7.9% in controls. Multiple logistic regression analysis demonstrated that ESR, CRP and genetic markers were the most relevant independent variables and when combined could indicate the outcome in early RA. These data confirmed that different RA subtypes with different prognoses could be associated with particular clinical, biological and genetic profiles. Moreover, some of these factors could serve as predictive markers for outcome at the onset of RA.
回顾性研究了47例患有严重关节损伤的类风湿性关节炎(RA)患者(第1组)和47例放射学异常有限的患者(第2组)发病时的临床和生物学特征以及人类白细胞抗原分型。两组根据病程(平均:8.1年)进行匹配。第1组全身表现更常见。第1组的红细胞沉降率(ESR)、血小板计数、C反应蛋白(CRP)、类风湿因子和IgG滴度更高,血红蛋白水平更低。HLA II类基因分型显示,第1组95.7%的患者为Dw4、Dw14或DR1,而第2组为55.3%,正常对照组为37.1%。第1组34.1%的患者检测到两个与RA相关的DRB1基因,第2组为8.5%,对照组为7.9%。多因素logistic回归分析表明,ESR、CRP和遗传标记是最相关的独立变量,联合使用时可提示早期RA的预后。这些数据证实,具有不同预后的不同RA亚型可能与特定的临床、生物学和遗传特征相关。此外,其中一些因素可作为RA发病时预后的预测指标。